STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Clinical trials for STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tackles cancer in HIV patients
Disease control OngoingThis early-phase trial tests the safety of combining two cancer drugs, nivolumab and cabozantinib, in people with HIV who have advanced solid tumors. Only 8 participants were enrolled. The goal is to see if the combination is safe and can shrink or stabilize tumors.
Matched conditions: STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Friends and fitness: key to life after cancer?
Knowledge-focused OngoingThis study follows 250 young adult cancer survivors to see how their social relationships and physical activity change over time and how these factors affect their quality of life. Participants wear an activity tracker and complete surveys. The goal is to learn how to better supp…
Matched conditions: STAGE III THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC